Featured News

Combination therapy could simplify treatment and improve survival.

Dr. Mohamed Abdel-Mohsen’s Pioneering Research on Siglecs Spotlights Their Role Helping the Immune System Recognize Viral Infections, and as Promising Future Therapy

“Our hope is to build a center with the same reflection of Wistar in science and administration.”

More than 1,000 supporters gathered in Fairmont Park for PanCAN PurpleStride Philadelphia 2023 to support the Pancreatic Cancer Action Network (PanCAN). Wistar’s Dr. Rahul Shinde is a PanCAN research grant recipient, and our lab was honored to attend the event and represent the scientific community. People of all ages wore purple to show support with many teams commemorating loved ones lost. I, too, walked in memory of a good friend and uncle who both lost their battles with pancreatic cancer. 

It is often said that the measure of a person is in more than just their accomplishments. For Dario Altieri, CEO of The Wistar Institute, trying to sum up the tenure of Joe Trainor, who will be retiring this month as Wistar’s Chief Financial Officer, is not as easy as just rattling off his many achievements.